TRVI Smart Money
Trevi Therapeutics, Inc.
1W: +4.0%
1M: -7.3%
3M: -26.2%
YTD: +12.3%
1Y: +27.0%
3Y: +645.8%
5Y: +1021.9%
$13.35
+0.84 (+6.71%)
Pre-Market: $13.43 (+0.08, +0.56%)
Weekly Expected Move ±5.9%
$11
$12
$13
$13
$14
Credit Risk of going bust: lower than 92% of companies Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Trevi Therapeutics, Inc. would be worth roughly what it owes.
Total debt $605K against a stock market value of $1.90B.
Distance to default 14.96 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $302K (short-term plus half of long-term), stock volatility 57.6%; Altman Z'' 39.15. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), Trevi Therapeutics, Inc. would be worth roughly what it owes.
Total debt $605K against a stock market value of $1.90B.
Distance to default 14.96 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $302K (short-term plus half of long-term), stock volatility 57.6%; Altman Z'' 39.15. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026242
Institutions Holding
+20 vs prior
146.2%
Ownership
+61.32%
46
New
88
Increased
79
Reduced
20
Closed
👔 Insider Trades
7 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Heffernan Michael Thomas | director | S-Sale | 18,321 | $15.09 | $276K | Filing |
| 2026-09-15 | Heffernan Michael Thomas | director | S-Sale | 20,952 | $15.09 | $316K | Filing |
| 2026-09-15 | Heffernan Michael Thomas | director | S-Sale | 100 | $15.88 | $2K | Filing |
| 2025-03-25 | SCIASCIA THOMAS | officer: chief scientific officer | S-Sale | 2,631 | $6.60 | $17K | Filing |
| 2025-03-21 | GOOD JENNIFER L | officer: president & ceo | S-Sale | 5,263 | $6.58 | $35K | Filing |
| 2025-03-10 | Simon Farrell | officer: chief commercial officer | S-Sale | 76,963 | $6.73 | $518K | Filing |
| 2025-03-10 | Simon Farrell | officer: chief commercial officer | S-Sale | 4,350 | $7.15 | $31K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 13,222,228 | $247M | — | 2026-06-30 | Filing |
| FMR LLC | 12,562,839 | $234M | +4,524,778 | 2026-06-30 | Filing |
| BlackRock, Inc. | 11,155,026 | $208M | +914,840 | 2026-06-30 | Filing |
| Frazier Life Sciences Management, L.P. | 9,939,447 | $185M | -100 | 2026-06-30 | Filing |
| WELLINGTON MANAGEMENT GROUP LLP | 5,684,592 | $106M | +495,504 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,530,675 | $103M | +552,108 | 2026-06-30 | Filing |
| Vivo Capital, LLC | 5,094,668 | $95M | — | 2026-06-30 | Filing |
| Woodline Partners LP | 4,081,333 | $76M | +3,080,551 | 2026-06-30 | Filing |
| Vestal Point Capital, LP | 3,100,000 | $58M | +933,496 | 2026-06-30 | Filing |
| MPM BIOIMPACT LLC | 3,073,577 | $57M | -224,853 | 2026-06-30 | Filing |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,070,740 | $57M | +1,076,448 | 2026-06-30 | Filing |
| STATE STREET CORP | 3,027,315 | $56M | +362,002 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2,928,068 | $55M | +149,837 | 2026-06-30 | Filing |
| MARSHALL WACE, LLP | 2,674,137 | $50M | -1,291,882 | 2026-06-30 | Filing |
| EVENTIDE ASSET MANAGEMENT, LLC | 2,660,000 | $50M | +37,694 | 2026-06-30 | Filing |
| Rubric Capital Management LP | 2,504,513 | $47M | -1,207,860 | 2026-06-30 | Filing |
| Artia Global Partners LP | 2,210,852 | $41M | +197,250 | 2026-06-30 | Filing |
| ACORN CAPITAL ADVISORS, LLC | 2,144,844 | $40M | — | 2026-06-30 | Filing |
| First Light Asset Management, LLC | 2,097,215 | $39M | +2,097,215 | 2026-06-30 | Filing |
| Pictet Asset Management Holding SA | 2,013,786 | $38M | +307,738 | 2026-06-30 | Filing |